U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07016516) titled 'A Study to Learn About PRT-064040 Nasal Spray in Healthy Adult Subjects' on May 27.
Brief Summary: This trial is a Phase I, single-center, randomized, double-blind, placebo-controlled study conducted in healthy Chinese adult subjects.
The purpose of this study is to learn about:
* Safety and tolerability of PRT-064040 nasal spray in healthy adult subjects.
* Pharmacokinetics after single and multiple dose of PRT-064040 nasal spray in healthy Chinese adult subjects.
This study is divided into two parts:
* Eligible subjects in Part A will receive a single dose of PRT-064040 nasal spray or placebo.
* Eligible subjects in Part B w...